ConductScience.org, home

Paper508556

The interaction of varying doses of dipyridamole and acetyl salicylic acid on the inhibition of platelet functions and their effect on bleeding time.

Rajah SM and 4 others. Br J Clin Pharmacol, 1979. Cited by 38 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The interaction of varying doses of dipyridamole and acetyl salicylic acid on the inhibition of platelet functions and their effect on bleeding time. Papers, record 508556. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/508556

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The interaction of varying doses of dipyridamole and acetyl salicylic acid on the inhibition of platelet functions and their effect on bleeding time.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1979
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
38
iCite
Relative citation ratio, by iCite
1.65
iCite
Revised in PubMed
2019-05-09
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rajah SMS M
2Penny AFA F
3Crow MJM J
4Pepper MDM D
5Watson DAD A

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AspirinMajor topic
Blood CoagulationMajor topic
Blood PlateletsMajor topic
DipyridamoleMajor topic
Adult
Bleeding Time
Dose-Response Relationship, Drug
Drug Interactions
Female
Humans
Male
Middle Aged
Platelet Aggregation

Source PubMed

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
113,871,375Aggregation of blood platelets by adenosine diphosphate and its reversal.Nature1962https://conductscience.org/library/papers/13871375PubMed
363,657Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation.Lancet1977https://conductscience.org/library/papers/63657PubMed
478,050Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin.Lancet1978https://conductscience.org/library/papers/78050PubMed
5191,877Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets.Prostaglandins1977https://conductscience.org/library/papers/191877PubMed
6148,119Evaluation of the thrombo-resistant properties of arterial grafts in an artificial circulation.Thromb Res1978https://conductscience.org/library/papers/148119PubMed
7907,679Cultured human skin fibroblasts and arterial cells produce a labile platelet-inhibitory prostaglandin.Biochem Biophys Res Commun1977https://conductscience.org/library/papers/907679PubMed
8871,376The synergistic effect of aspirin and dipyridamole upon platelet thrombi in living blood vessels.Br J Exp Pathol1977https://conductscience.org/library/papers/871376PubMed
9861,128The effect of dipyridamole on platelet function: correlation with blood levels in man.Br J Clin Pharmacol1977https://conductscience.org/library/papers/861128PubMed
10795,299Are agents affecting platelet functions clinically useful?Am J Med1976https://conductscience.org/library/papers/795299PubMed
114,101,110Metrication and medicine.Lancet1971https://conductscience.org/library/papers/4101110PubMed
124,176,225The effect of acetylsalicyclic acid on platelet function.J Exp Med1968https://conductscience.org/library/papers/4176225PubMed
134,330,088The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets.Biochem J1971https://conductscience.org/library/papers/4330088PubMed
144,471,695An endoperoxide aggregator (Lass), formed in platelets in response to thrombotic stimuli: purification, identification and unique biological significance.Prostaglandins1974https://conductscience.org/library/papers/4471695PubMed
15176,688Aspirin as a quantitative acetylating reagent for the fatty acid oxygenase that forms prostaglandins.Prostaglandins1976https://conductscience.org/library/papers/176688PubMed
164,682,731Inhibition of thrombosis on vascular catheters in cats.Radiology1973https://conductscience.org/library/papers/4682731PubMed
17785,989Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis.Am Heart J1976https://conductscience.org/library/papers/785989PubMed
181,059,088Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.Proc Natl Acad Sci U S A1975https://conductscience.org/library/papers/1059088PubMed
195,478,451Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves.N Engl J Med1970https://conductscience.org/library/papers/5478451PubMed
205,416,902Platelet function studies in human beings receiving 300 mg. of aspirin per day.J Lab Clin Med1970https://conductscience.org/library/papers/5416902PubMed
215,794,116The standardized normal Ivy bleeding time and its prolongation by aspirin.Blood1969https://conductscience.org/library/papers/5794116PubMed

See all 21 references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.

PMIDTitleJournalYearIn PapersSource
24,043,375Comparative efficacy of in vitro and in vivo metabolized aspirin in the DeBakey ventricular assist device.J Thromb Thrombolysis2014https://conductscience.org/library/papers/24043375PubMed
17,704,986[Herb-drugs interactions].Wien Med Wochenschr2007https://conductscience.org/library/papers/17704986PubMed
7,712,662Pharmacokinetic optimisation of the treatment of embolic disorders.Clin Pharmacokinet1995https://conductscience.org/library/papers/7712662PubMed
7,049,287Effect of dipyridamole on the formation of 6-oxo-prostaglandin F1 alpha by the rat isolated aorta and ram seminal vesicle microsomes.Br J Pharmacol1982https://conductscience.org/library/papers/7049287PubMed
3,926,237Medical ethics and the potentialities of the living being.Br Med J (Clin Res Ed)1985https://conductscience.org/library/papers/3926237PubMed
2,825,745Dipyridamole: pharmacokinetics and effects on aspects of platelet function in man.Br J Clin Pharmacol1987https://conductscience.org/library/papers/2825745PubMed
1,289,367Phosphodiesterase-inhibitors enoximone and piroximone in cardiac surgery: influence on platelet count and function.Intensive Care Med1992https://conductscience.org/library/papers/1289367PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PF45,196PubTator's text mininghttps://conductscience.org/library/genes/5196

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/508556

GET https://conductscience.org/api/papers/v1/508556/references?page=2